Furthermore, TLR2 expression is also upregulated in oligodendrocytes of MS, which inhibits the maturation of oligodendrocyte precursor cell (OPC) and remyelination through the activation of the TLR2-MyD88 signaling pathway (48) (Figure 2). This evidence concerns the gene TLR2 and myeloid sarcoma.